Related Experiment Video
Updated: May 31, 2026
09:49
Induction and Assessment of Class Switch Recombination in Purified Murine B Cells
Published on: August 13, 2010
Immunoglobulin class switch recombination in chronic lymphocytic leukemia
Mark C Lanasa1, J Brice Weinberg
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. mark.lanasa@duke.edu
Leukemia & Lymphoma
|June 25, 2011
Summary
Chronic lymphocytic leukemia (CLL) cells may undergo class switch recombination (CSR), altering antibody isotype production. This process could influence the clinical behavior and progression of CLL, impacting treatment strategies.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Background:
- B lymphocyte maturation involves class switch recombination (CSR) to diversify antibody effector functions.
- Chronic lymphocytic leukemia (CLL) cells typically co-express surface IgM and IgD, similar to naive B cells.
- A minority of CLL cases exhibit terminally differentiated antibody isotypes.
Purpose of the Study:
- To investigate the capacity of CLL cells to undergo CSR.
- To explore the clinical relevance of CSR in CLL.
Main Methods:
- Analysis of CLL cell populations for CSR markers.
- Correlation of CSR status with clinical parameters in CLL patients.
Main Results:
- CLL cells possess the potential to undergo CSR.
- CSR in CLL may be linked to specific clinical behaviors.
Conclusions:
- The ability of CLL cells to perform CSR is a significant biological feature.
- Understanding CSR in CLL can provide insights into disease progression and therapeutic targets.
Related Concept Videos
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:31Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...